Ropinirole prolonged release maintains a positive treatment response in patients with advanced Parkinson's disease (PD) not optimally controlled with L-Dopa

被引：0
|
作者：
Ruzicka, E. [1 ]
Hunter, B. [2 ]
Giorgi, L. [3 ]
Hersh, B. [4 ,5 ]
机构：
[1] Charles Univ Prague, Prague, Czech Republic
[2] GlaxoSmithKline Inc, Harlow, Essex, England
[3] GlaxoSmithKline Inc, Greenford, Middx, England
[4] Harvard Vanguard Med Associates, Boston, MA USA
[5] Harvard Univ, Sch Med, Boston, MA USA
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2009年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：522 / 522
页数：1
相关论文
共 50 条
  • [31] Nocturnal symptoms response in patients with advanced Parkinson's disease treated with ropinirole prolonged release or placebo
    Martinez-Martin, P.
    Coles, R.
    Rolfe, K.
    Lipschitz, A.
    Ondo, W.
    MOVEMENT DISORDERS, 2010, 25 (07) : S294 - S294
  • [32] The development of dyskinesias in Parkinson's disease patients receiving ropinirole and given supplemental L-dopa
    Lang, AE
    Rascol, O
    Brooks, DJ
    Clarke, CE
    De Deyn, PP
    Korczyn, AD
    Abdalla, M
    NEUROLOGY, 2002, 58 (07) : A82 - A82
  • [33] Adjunctive ropinirole 24-hour prolonged release compared with ropinirole immediate release in patients with advanced Parkinson's disease (PD): the PREPARED study
    Stocchi, F.
    Hunter, B.
    Giorgi, L.
    Schapira, A. H. V.
    EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 : 134 - 134
  • [34] Ropinirole 24-hour prolonged release is effective in patients with advanced Parkinson's disease as measured by treatment response and disease severity
    Pahwa, R.
    Stocchi, F.
    Giorgi, L.
    EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 : 63 - 63
  • [35] Improvements in nocturnal symptoms with ropinirole prolonged release in patients with advanced Parkinson's disease
    Chaudhuri, K. Ray
    Martinez-Martin, P.
    Rolfe, K. A.
    Cooper, J.
    Rockett, C. B.
    Giorgi, L.
    Ondo, W. G.
    EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 (01) : 105 - 113
  • [36] L-dopa response in Parkinson's disease - A study with L-dopa infusion test
    Saiki, H.
    Matsumoto, S.
    MOVEMENT DISORDERS, 2012, 27 : S50 - S50
  • [37] L-dopa response following pallidotomy in patients with Parkinson's disease
    Levy, R
    Fine, J
    Dostrovsky, JO
    Lozano, AM
    Lang, AE
    NEUROLOGY, 2000, 54 (07) : A187 - A187
  • [38] Effects of ropinirole prolonged release on sleep duration in patients with advanced Parkinson's disease (PD) with significant nocturnal symptoms
    Martinez-Martin, P.
    Reichmann, H.
    Cooper, J.
    Rolfe, K.
    Lipschitz, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2010, 17 : 387 - 387
  • [39] Conversion of L-dopa to Extended Release L-dopa (Rytary®) in Patients with Fluctuating Parkinson's Disease: Predictors of Dose
    Ondo, William
    Coss, Pablo
    Christie, Melissa
    Pascual, Belen
    JOURNAL OF PARKINSONS DISEASE, 2019, 9 (01) : 153 - 156
  • [40] Peculiarities of L-DOPA treatment of Parkinson’s disease
    R. M. Kostrzewa
    P. Nowak
    J. P. Kostrzewa
    R. A. Kostrzewa
    R. Brus
    Amino Acids, 2005, 28 : 157 - 164
12345